Powder metallurgical low-modulus Ti-Mg alloys for biomedical applications

Mater Sci Eng C Mater Biol Appl. 2015 Nov 1:56:241-50. doi: 10.1016/j.msec.2015.06.010. Epub 2015 Jun 12.

Abstract

In this work, powder metallurgical (PM) Ti-Mg alloys were prepared using combined techniques of mechanical alloying and spark plasma sintering. The alloys mainly consist of super saturations of Mg in Ti matrix, and some laminar structured Ti- and Mg-rich phases. The PM Ti-Mg alloys contain a homogeneous mixtures of nanocrystalline Mg and Ti phases. The novel microstructures result in unconventional mechanical and biological properties. It has been shown that the PM Ti-Mg alloys have a much lower compression modulus (36-50GPa) compared to other Ti alloys, but still remain a very high compressive strength (1500-1800MPa). In addition, the PM Ti-Mg alloys show good biocompatibility and bioactivity. Mg can dissolve in the simulated body fluids, and induce the formation of the calcium phosphate layer. The compression modulus of PM Ti-Mg alloys decreases with the amount of Mg, while the bioactivity increases. Although the corrosion resistance of Ti-Mg alloys decreases with the content of Mg, the alloys still show good stability in simulated body fluid under electrochemical conditions. The indirect and direct cytotoxicity results show that PM Ti-Mg alloys have a good biocompatibility to NIH-3T3 cells. Therefore, the PM Ti-Mg alloys are promising candidates in biomedical applications.

Keywords: Bioactivity; Biomaterials; Mechanical behavior; Powder metallurgy; Ti–Mg alloy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alloys* / chemistry
  • Alloys* / pharmacology
  • Animals
  • Manganese* / chemistry
  • Manganese* / pharmacology
  • Materials Testing*
  • Metallurgy
  • Mice
  • NIH 3T3 Cells
  • Titanium* / chemistry
  • Titanium* / pharmacology

Substances

  • Alloys
  • Manganese
  • Titanium